405 related articles for article (PubMed ID: 31653199)
1. Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients.
Chen H; Watnick T; Hong SN; Daly B; Li Y; Seliger SL
BMC Nephrol; 2019 Oct; 20(1):386. PubMed ID: 31653199
[TBL] [Abstract][Full Text] [Related]
2. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
Perrone RD; Abebe KZ; Schrier RW; Chapman AB; Torres VE; Bost J; Kaya D; Miskulin DC; Steinman TI; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Kelleher C; Masoumi A; Glockner J; Halin NJ; Martin D; Remer E; Patel N; Pedrosa I; Wetzel LH; Thompson PA; Miller JP; Bae KT; ; Meyers CM
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2508-15. PubMed ID: 21903983
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner.
Pietrzak-Nowacka M; Safranow K; Czechowska M; Dutkiewicz G; Kornacewicz-Jach Z; Ciechanowski K
Kidney Blood Press Res; 2012; 36(1):301-9. PubMed ID: 23235185
[TBL] [Abstract][Full Text] [Related]
5. Morning blood pressure surge in early autosomal dominant polycystic kidney disease and its relation with left ventricular hypertrophy.
Yildiz A; Sag S; Gul CB; Güllülü S; Can FE; Bedir Ö; Aydin MF; Oruç A; Demirel S; Akgür S; Güllülü M; Ersoy A
Ren Fail; 2021 Dec; 43(1):223-230. PubMed ID: 33478355
[TBL] [Abstract][Full Text] [Related]
6. Epicardial Fat Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease.
Concistrè A; Petramala L; Scoccia G; Sciomer S; Bisogni V; Saracino V; Iannucci G; Lai S; Mastroluca D; Iacobellis G; Letizia C
Cardiorenal Med; 2018; 8(3):199-207. PubMed ID: 29723863
[TBL] [Abstract][Full Text] [Related]
7. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
Miskulin DC; Abebe KZ; Chapman AB; Perrone RD; Steinman TI; Torres VE; Bae KT; Braun W; Winklhofer FT; Hogan MC; Rahbari-Oskoui F; Moore CG; Flessner MF; Schrier RW;
Am J Kidney Dis; 2014 Feb; 63(2):214-26. PubMed ID: 24183837
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
Ruebner RL; Ng D; Mitsnefes M; Foster BJ; Meyers K; Warady B; Furth SL
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1962-1968. PubMed ID: 27630183
[TBL] [Abstract][Full Text] [Related]
10. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
[TBL] [Abstract][Full Text] [Related]
11. Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.
Brady TM; Roem J; Cox C; Schneider MF; Wilson AC; Furth SL; Warady BA; Mitsnefes M
Am J Kidney Dis; 2020 Aug; 76(2):166-173. PubMed ID: 32389356
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy in nondiabetic predialysis CKD.
Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
[TBL] [Abstract][Full Text] [Related]
13. Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state.
Martinez-Vea A; Bardaj A; Gutierrez C; Garca C; Peralta C; Marcas L; Oliver JA
Am J Kidney Dis; 2004 Aug; 44(2):216-23. PubMed ID: 15264179
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease.
Valero FA; Martinez-Vea A; Bardají A; Gutierrez C; Garcia C; Richart C; Oliver JA
J Am Soc Nephrol; 1999 May; 10(5):1020-6. PubMed ID: 10232688
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Chapman AB; Johnson AM; Rainguet S; Hossack K; Gabow P; Schrier RW
J Am Soc Nephrol; 1997 Aug; 8(8):1292-7. PubMed ID: 9259356
[TBL] [Abstract][Full Text] [Related]
16. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
17. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
[TBL] [Abstract][Full Text] [Related]
19. Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension.
Perticone F; Maio R; Ruberto C; Cassano S; Tripepi G; Perticone M; Sesti G; Zoccali C
Am J Kidney Dis; 2008 Jul; 52(1):74-84. PubMed ID: 18423813
[TBL] [Abstract][Full Text] [Related]
20. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
